The U.S. Food and Drug Administration (FDA) recently issued a draft guidance, “Master Protocols for Drug and Biological Product Development”, that echoes and builds on principles that the Agency ...

The US Food and Drug Administration (FDA) has issued new guidance describing its current recommendations with respect to master protocols for the evaluation of drugs and biologics to treat or prevent ...

As compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cancer Master Protocol (Lung-MAP) has enrolled higher percentages of ...

SINGAPORE / ACCESSWIRE / June 24, 2024 / The Bitcoin ecosystem has taken a significant leap forward with the launch of the Master Yield Market, a pioneering product from Master Protocol. With its ...

Five biopharma companies will soon be testing their lung cancer compounds in a very different type of clinical trial. The Lung Cancer Master Protocol will test multiple novel drugs simultaneously ...

Financing extends Company’s cash runway beyond important clinical milestones anticipated beginning in 2H25, supporting the ongoing execution of the FORTE Master Protocol evaluating plixorafenib as a ...

To accelerate drug development targeting the pandemic, the FDA issued final guidance May 17 on master protocols for drugs intended to prevent or treat COVID-19 infections. Although the guidance is ...

Business as usual has not been the mantra for companies developing Covid-19 vaccines and drugs. Instead, biopharma companies and their partners pursued various transformational approaches to get ...

Pilot project will bring drug companies together to test targeted lung-cancer therapies. You have full access to this article via your institution. In the push to match medical therapies to the ...